DWM
CRDF icon

Denver Wealth Management’s Cardiff Oncology CRDF Stock Holding History

Denver Wealth Management’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-15,235
Closed -$48K – 93
2025
Q2 		$48K Hold
15,235
– – 0.02% 87
2025
Q1 		$47.8K Hold
15,235
– – 0.02% 86
2024
Q4 		$66.1K Hold
15,235
– – 0.03% 82
2024
Q3 		$40.7K Hold
15,235
– – 0.02% 87
2024
Q2 		$33.8K Buy
15,235
+3,000
+25% +$11.3K 0.02% 83
2024
Q1 		$65.3K Sell
12,235
-8,000
-40% -$21.3K 0.03% 79
2023
Q4 		$29.9K Buy
20,235
+2,000
+11% +$2.42K 0.02% 75
2023
Q3 		$25.3K Hold
18,235
– – 0.02% 71
2023
Q2 		$26.8K Hold
18,235
– – 0.02% 71
2023
Q1 		$30.1K Buy
+18,235
New +$31.3K 0.02% 80

Other funds holding CRDF

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $8.39B AUM 37.75% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Denver Wealth Management's CRDF Position: Q3 2025 in Review

Denver Wealth Management sold out of Cardiff Oncology (CRDF) in Q3 2025, closing a stake of 15,235 shares — an estimated $48K sold.

Denver Wealth Management first reported a position in CRDF in Q1 2023 and held it in 10 quarters. The position peaked at $66.1K in Q4 2024. 112 funds tracked by Wall St. Rank hold CRDF as of Q3 2025.

  • Denver Wealth Management reported no remaining Cardiff Oncology position as of Q3 2025 after selling out during the quarter.
  • Denver Wealth Management sold 15,235 Cardiff Oncology shares in Q3 2025, an estimated $48K.
  • Denver Wealth Management first reported a position in Cardiff Oncology in Q1 2023 and held it in 10 quarters.
  • Denver Wealth Management's Cardiff Oncology position peaked at $66.1K in Q4 2024.
  • 112 funds tracked by Wall St. Rank held Cardiff Oncology as of Q3 2025.

Based on Denver Wealth Management's 13F filing for Q3 2025, filed 12 Nov 2025.